Allelic and genotypic frequencies in the skin cancer patient and control groups
| Polymorphism | Normal (%) | Skin cancer (%) | Significance | |
|---|---|---|---|---|
| CCR5Δ32 | ||||
| Number of samples | 361 | 110 | ||
| Wild/wild | 326 (90.3) | 103 (93.6) | p = 0.283 | NO |
| Wild/mutated | 35 (9.6) | 7 (6.4) | df = 2 | |
| Mutated/mutated | 0 | 0 | ||
| Allele frequency | 0.0484 | 0.0318 | p = 0.294 | NO |
| Hardy–Weinberg | YES | YES | df = 1 | |
| CXCL12 | ||||
| Number of samples | 363 | 110 | ||
| Wild/wild | 169 (46.5) | 64 (58.1) | p = 0.097 | NO |
| Wild/mutated | 164 (45.2) | 38 (34.5) | df = 2 | |
| Mutated/mutated | 30 (8.3) | 8 (7.2) | ||
| Allele frequency | 0.3085 | 0.2454 | p = 0.071 | NO |
| Hardy–Weinberg | YES | YES | df = 1 | |
| CCR2-64I | ||||
| Number of samples | 362 | 110 | ||
| Wild/wild | 271 (74.9) | 74 (67.3) | p = 0.234 | NO |
| Wild/mutated | 84 (23.2) | 32 (29.1) | df = 2 | |
| Mutated/mutated | 7 (1.9) | 4 (3.6) | ||
| Allele frequency | 0.1353 | 0.1818 | p = 0.087 | NO |
| Hardy–Weinberg | YES | YES | df = 1 | |
| CCR5 59029 G-A | ||||
| Number of samples | 306 | 110 | ||
| Wild/wild | 80 (26.1) | 29 (26.4) | p = 0.720 | NO |
| Wild/mutated | 145 (47.4) | 56 (50.9) | df = 2 | |
| Mutated/mutated | 81 (26.5) | 25 (22.7) | ||
| Allele frequency | 0.5016 | 0.4818 | p = 0.614 | NO |
| Hardy–Weinberg | YES | YES | df = 1 | |